AnalystsMatt LarewMatt Larew's Stock Forecasts
AnalystsMatt Larew
Analyst Ranking
Bottom 11%
#4085 out of 4565 analysts
Average Return
-66.08%
Win Rate
0%0 out of 6
Risk vs Reward
Poor
Good
Matt Larew's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
No Ratings AvailableMatt Larew doesn't have any winning ratings in our database | |||||
Matt Larew Analyst Color
Get additional color on Matt Larew's coverage of popular stocks
Matt Larew's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Signify Health IncSGFY | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Ginkgo Bioworks Holdings IncDNA | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Innovage Holding CorpINNV | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Maxcyte IncMXCT | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Zymergen IncZY | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Twist Bioscience CorpTWST | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.